Pharma Export
- All
- News
- Videos
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
India Seeks Russia's Nod for Marine, Pharma Exports to Boost Trade
India has asked Russia to facilitate expedited listing of domestic establishments and registration of marine and pharma products with a view to boost two-way trade.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
Maiden Pharma Founder, Another Official Jailed In Decade-Old Case: Report
Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Government Eases Export Curbs On 24 Pharma Ingredients, Medicines
The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
India Seeks Russia's Nod for Marine, Pharma Exports to Boost Trade
India has asked Russia to facilitate expedited listing of domestic establishments and registration of marine and pharma products with a view to boost two-way trade.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
Maiden Pharma Founder, Another Official Jailed In Decade-Old Case: Report
Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Government Eases Export Curbs On 24 Pharma Ingredients, Medicines
The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
